{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:08:11Z","timestamp":1767665291113,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.maturitas.2003.12.009","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T05:24:27Z","timestamp":1079414667000},"page":"259-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Venous and arterial thrombosis: epidemiology and risk factors at various ages"],"prefix":"10.1016","volume":"47","author":[{"given":"Gordon D.O.","family":"Lowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2003.12.009_BIB1","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analyses\u2014sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/01.CIR.0000016346.14762.71","article-title":"Physical activity and hemostatic and inflammatory variables in elderly men","volume":"105","author":"Wannamethee","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2141.2003.04387.x","article-title":"C-reactive protein: associations with haematological variables, cardiovascular risk factors, and prevalent cardiovascular disease","volume":"121","author":"Woodward","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.1997.1222936.x","article-title":"Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use","volume":"97","author":"Lowe","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2141.1999.01158.x","article-title":"Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease","volume":"104","author":"Woodward","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1055\/s-0037-1614599","article-title":"Activated protein C resistance and the FV: R506Q mutation in a random population sample: associations with cardiovascular risk factors and coagulation variables","volume":"81","author":"Lowe","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"22","author":"Rosendaal","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB8","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB9","unstructured":"Prophylaxis of venous thromboembolism. A national clinical guideline. (SIGN guideline 62) Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh, 2002."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.313.7065.1127","article-title":"Factor V Leiden: should we screen oral contraceptive users and pregnant women?","volume":"313","author":"Vandenbroucke","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.0007-1048.2002.03356.x","article-title":"Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis","volume":"116","author":"Rosendaal","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB12","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJM199506293322607","article-title":"The primary prevention of coronary heart disease in women","volume":"332","author":"Rich-Edwards","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB13","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.CIR.92.6.1430","article-title":"Combined effects of HDL cholesterol, triglycerides, and total cholesterol concentrations on 18-year risk of atherosclerotic disease","volume":"92","author":"Burchfield","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/euhj.1999.1699","article-title":"Haematocrit, viscosity, erthryocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease","volume":"21","author":"Danesh","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(97)11321-6","article-title":"Myth and paradox of coronary risk and the menopause","volume":"351","author":"Tunstall-Pedoe","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1701-2163(16)30471-6","article-title":"The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women","volume":"24","author":"Blake","year":"2002","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organisation MONICA project","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/bmj.315.7110.722","article-title":"Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study","volume":"315","author":"Tunstall-Pedoe","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00043798-200204000-00001","article-title":"Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study","volume":"9","author":"Jonsdottir","year":"2002","journal-title":"J. Cardiovasc. Risk"},{"issue":"Suppl. 2","key":"10.1016\/j.maturitas.2003.12.009_BIB20","first-page":"s1","article-title":"Joint British recommendations on prevention of coronary heart disease in clinical practice","volume":"80","author":"Wood","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the Women\u2019s Health Initiative Observational Study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2003.12.009_BIB22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000073592","article-title":"Hormone replacement therapy: prothrombotic vs. protective effects","volume":"32","author":"Lowe","year":"2003","journal-title":"J. Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.maturitas.2003.12.009_BIB23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851220400012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851220400012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:38:11Z","timestamp":1759912691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851220400012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S037851220400012X"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2003.12.009","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous and arterial thrombosis: epidemiology and risk factors at various ages","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2003.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}